Larkspur Biosciences

About:

Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.

Website: https://larkspur.bio

Twitter/X: LarkspurBio

Top Investors: Polaris Partners, 3E Bioventures, Takeda Ventures

Description:

Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.

Total Funding Amount:

$35.5M

Headquarters Location:

Watertown, Massachusetts, United States

Founded Date:

2020-01-01

Founders:

Lewis C. Cantley, Nathanael Gray, Vijay Kuchroo

Number of Employees:

11-50

Last Funding Date:

2023-05-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai